FDG-PET in the management of germ cell tumor

被引：15
作者：
De Giorgi, Ugo [1 ]
Pupi, A. [2 ]
Fiorentini, G. [1 ]
Rosti, G. [3 ]
Marangolo, M. [3 ]
机构：
[1] San Guiseppe Hosp, Dept Oncol, Ist Toscani Tumori, I-50053 Florence, Italy
[2] Univ Florence, Nucl Med Unit, Dept Clin Pathophysiol, Florence, Italy
[3] Santa Maria Croci Hosp, Dept Oncol & Hematol, Ist Oncol Romagnolo, Ravenna, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
10.1093/annonc/mdi915
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Germ cell tumor is the most common malignancy in young men. The cure rate of these patients has tremendously increased in the cisplatin era, and recent results have indicated that the management of patients with GCT is still improving. The use of FDG-PET in the management of patients with GCT has been recently investigated. This report attempts to comprehensively review new advances and delineate the potential applications of FDG-PET in GCT.
引用
收藏
页码：90 / 94
页数：5
相关论文
共 39 条
[1]   Positron emission tomography in the clinical staging of patients with stage I and II testicular germ cell tumors [J].
Albers, P ;
Bender, H ;
Yilmaz, H ;
Schoeneich, G ;
Biersack, HJ ;
Mueller, SC .
UROLOGY, 1999, 53 (04) :808-811
[2]  
[Anonymous], 1997, J Clin Oncol, V15, P594
[3]  
Barthel H, 2003, CANCER RES, V63, P3791
[4]   Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET [J].
Bokemeyer, C ;
Kollmannsberger, C ;
Oechsle, K ;
Dohmen, BM ;
Pfannenberg, A ;
Claussen, CD ;
Bares, R ;
Kanz, L .
BRITISH JOURNAL OF CANCER, 2002, 86 (04) :506-511
[5]   Fluorinated tracers for imaging cancer with positron emission tomography [J].
Couturier, O ;
Luxen, A ;
Chatal, JF ;
Vuillez, JP ;
Rigo, P ;
Hustinx, R .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (08) :1182-1206
[6]   2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma:: An update of the prospective multicentric SEMPET trial [J].
De Santis, M ;
Becherer, A ;
Bokemeyer, C ;
Stoiber, F ;
Oechsle, K ;
Sellner, F ;
Lang, A ;
Kletter, K ;
Dohmen, BM ;
Dittrich, C ;
Pont, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1034-1039
[7]   The role of positron emission tomography in germ cell cancer [J].
De Santis, M ;
Pont, J .
WORLD JOURNAL OF UROLOGY, 2004, 22 (01) :41-46
[8]   Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma [J].
De Santis, M ;
Bokemeyer, C ;
Becherer, A ;
Stoiber, F ;
Oechsle, K ;
Kletter, K ;
Dohmen, BM ;
Dittrich, C ;
Pont, J .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) :3740-3744
[9]   Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors [J].
Fizazi, K ;
Culine, S ;
Kramar, A ;
Amato, RJ ;
Bouzy, J ;
Chen, I ;
Droz, JP ;
Logothetis, CJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3868-3876
[10]   Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma [J].
Ganjoo, KN ;
Chan, RJ ;
Sharma, M ;
Einhorn, LH .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) :3457-3460
1234